Oryzon Genomics SA (ORYZF)
3.31
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
Oryzon Genomics Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pharma Mar SA | -37.88M |
| Grifols SA | -156.60M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alkermes Plc | -2.411M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |